Clinical trial
Observation of Long Term Effect of Medical and PTPA Treatment on Patients With Takayasu Arteritis Complicated With Pulmonary Artery Involvement
NCT05388682 is registered in ClinicalTrials.gov with Chinese Pulmonary Vascular Disease Research Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Observation of Long Term Effect of Medical and PTPA Treatment on Patients With Takayasu Arteritis Complicated With Pulmonary Artery Involvement
- Lead sponsor
- Chinese Pulmonary Vascular Disease Research Group
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- January 19, 2014
- Completion date
- December 31, 2042
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pah targeted medication, percutaneous transluminal pulmonary angioplasty, takayasu arteritis with pulmonary artery involvement